UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results